DUBLIN--(BUSINESS WIRE)--The "Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%
Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.)
The specimen validity testing market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period; growth in this segment is attributed to the growing implementation of workplace drug testing in several countries, increasing number of drug screening tests, and the growing number of drug screening laboratories across the globe.
The specimen validity testing market is segmented into laboratory testing and rapid/POC testing. The laboratory testing segment is expected to dominate the market during the forecast period. The accuracy of test results and cost-effectiveness of laboratory testing are other key factors driving the demand for this segment.
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. The high growth in the APAC regional segment is attributed to the developing healthcare infrastructure, rising adoption of stringent regulatory guidelines for drug testing, increase in the number of illicit drug users, and strategic expansion of key market players in the region.
Key Topics Covered:
- Research Methodology
- Executive Summary
- Premium Insights
- Market Overview
- Specimen Validity Testing Market, By Product & Service
- Specimen Validity Testing Market, By Type
- Specimen Validity Testing Market, By End User
- Specimen Validity Testing Market, By Region
- Competitive Landscape
- Company Profiles
- Alere (Subsidiary of Abbott Laboratories)
- Thermo Fisher Scientific
- Quest Diagnostics
- American Bio Medica Corporation (ABMC)
- Premier Biotech
- Alfa Scientific Designs
- ACM Global Laboratories
- Express Diagnostic International
- Clinical Reference Laboratory
For more information about this report, visit https://www.researchandmarkets.com/research/hsl63z/specimen_validity?w=4.